Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Clinical Proteomics: Diagnostics and Prognostic Markers of Cancer

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line, Clinical Proteomics

Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus

Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review - The Lancet Oncology

Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers - Terkelsen - 2021 - Molecular Oncology - Wiley Online Library

Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis

Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review)

Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer

Proteomic-based stratification of intermediate-risk prostate cancer patients

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival, Genome Medicine

Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery